img-1
cta-img-1

Generated
by AI

cta-img-2

100% SEO
optimized

cta-img-3

Grammarly
checked

cta-img-4

Plagiarism
Free

Generate your first blog article

No credit card required

As the number of coronavirus cases in China continues to rise, the country is working to close the immunity gap by vaccinating more people.

Photo by Pranidchakan Boonrom on Pexels

Disclaimer: This article was generated by Texta.ai and shows the potential of AI-powered writing.
Try the free trial now to see how easy it is to generate articles.

China’s “zero covid” strategy exposes a critical flaw: a vast population without natural immunity.

With only occasional hot spots in the country, most of its 1.4 billion people have never been exposed to the virus.

China is scrambling to protect the most vulnerable populations with a more aggressive vaccine drive to boost immunity.

The elderly, who have an especially low vaccination rate, are a key target.

The Chinese government is targeting the elderly population with a more aggressive vaccine drive to boost immunity. The elderly have an especially low vaccination rate, and the government is hoping to increase this number. The government is also expanding hospital capacity and restricting the movement of at-risk groups in an effort to break cycles of disruptive lockdowns.

The first deaths to be reported since May — though only one or two per day — have intensified concerns that hospitals are poorly prepared to handle a surge in severe cases.

Bloomberg Intelligence estimated that fully relaxing coronavirus controls could leave 5.8 million Chinese needing intensive care in a system with only four beds per 100,000 people.

Subsection 3.2 Major cities including Beijing, Guangzhou and Chongqing have ordered residents in certain neighborhoods to stay at home. Shopping malls, museums and schools have been closed once more.

China has still not approved any foreign vaccines or explained its decision to shun what could be an effective way to plug its immunity gap.

When asked last week if the government would approve BioNTech for public use, the director of the Chinese Center of Disease Prevention and Control said authorities were working on a new vaccination plan to be released soon.

‍‍

No Responsibility Disclaimer for AI Blog Writer
The articles on texta.ai are generated by an AI-powered article writer and are for demonstration purposes only. Texta.ai does not endorse, condone, or take responsibility for any content on texta.ai. Please use caution when reading articles on texta.ai and always consult with a trusted news source.
By using texta.ai, you understand and agree that Texta.ai is not responsible for any content on the site, and you use the site at your own risk.
Texta.ai may contain links to external websites. Texta.ai is not responsible for the content of external websites and you use any external website linked from texta.ai/news at your own risk.
Thank you for using Texta.ai.